Another report showed that ibrutinib treatment significantly impaired integrin-α(4)β(1)-mediated adhesion of CLL cell lines or primary CLL cells to fibronectin or VCAM-1 [55]. The gene discussed is VCAM1; the disease is B-cell chronic lymphocytic leukemia.